Pleuro-pericarditis developed under a leflunomide therapy

被引：2

作者：

Vandenbos, F. ^{[1
,2
]}

Figueredo, M. ^{[1
]}

Tarhini, A. ^{[1
]}

Ribiere, J. ^{[3
]}

机构：

[1] Hop Clavary, Serv Pneumol, F-06135 Grasse, France

[2] Ctr Soins suite & Reeduc Maison Mineur, F-06141 Vence, France

[3] Hop Clavary, Serv Gerontol & Rhumatol, F-06135 Grasse, France

来源：

REVUE DE PNEUMOLOGIE CLINIQUE | 2015年 / 71卷 / 01期

关键词：

Leflunomide; Pericarditis; Pleural effusion; Psoriatic arthritis; RHEUMATOID-ARTHRITIS; DRUGS;

D O I：

10.1016/j.pneumo.2014.09.002

中图分类号：

R56 [呼吸系及胸部疾病];

学科分类号：

摘要：

Leflunomide is an immunosuppressant drug used in rheumatoid arthritis and psoriatic arthritis. This product may cause rare but serious interstitial lung disease that appear at the beginning of treatment. This is why leflunomide should be prescribed and monitored in hospital. We present the case of a 71 years old woman who presented a pleuro-pericarditis with an increase of CA 125 during a treatment with leflunomide. This is the second case reported in the literature. The outcome was favorable after discontinuation of leflunomide. (C) 2014 Elsevier Masson SAS. All rights reserved.

引用

页码：57 / 59

页数：3

共 11 条

[1] Pseudo-pseudo Meigs syndrome developed under the leflunomide therapy [J].

Bes, Cemal ;

Soy, Mehmet .

RHEUMATOLOGY INTERNATIONAL, 2011, 31 (04) :521-523

[2] Leflunomide: mode of action in the treatment of rheumatoid arthritis [J].

Breedveld, FC ;

Dayer, JM .

ANNALS OF THE RHEUMATIC DISEASES, 2000, 59 (11) :841-849

[3] Clinical expression of leflunomide-induced pneumonitis [J].

Chikura, Batsi ;

Lane, Steven ;

Dawson, Julie K. .

RHEUMATOLOGY, 2009, 48 (09) :1065-1068

[4] Efficacy and toxicity of methotrexate (MTX) monotherapy versus MTX combination therapy with non-biological disease-modifying antirheumatic drugs in rheumatoid arthritis: a systematic review and meta-analysis [J].

Katchamart, W. ;

Trudeau, J. ;

Phumethum, V. ;

Bombardier, C. .

ANNALS OF THE RHEUMATIC DISEASES, 2009, 68 (07) :1105-1112

[5]

MEIGS JV, 1954, OBSTET GYNECOL, V3, P471

[6] Drugs and the pleura [J].

Morelock, SY ;

Sahn, SA .

CHEST, 1999, 116 (01) :212-221

[7] The role of CA125 in clinical practice [J].

Moss, EL ;

Hollingworth, J ;

Reynolds, TM .

JOURNAL OF CLINICAL PATHOLOGY, 2005, 58 (03) :308-312

[8] Autoimmune diseases induced by TNF-targeted therapies -: Analysis of 233 cases [J].

Ramos-Casals, Manuel ;

Brito-Zeron, Pilar ;

Munoz, Sandra ;

Soria, Natalia ;

Galiana, Diana ;

Bertolaccini, Laura ;

Cuadrado, Maria-Jose ;

Khamashta, Munther A. .

MEDICINE, 2007, 86 (04) :242-251

[9] How to interpret serum CA 125 levels in patients with serosal involvement? A clinical dilemma [J].

Sevinc, A ;

Camci, C ;

Turk, HM ;

Buyukberber, S .

ONCOLOGY, 2003, 65 (01) :1-6

[10] Classification criteria for psoriatic arthritis - Development of new criteria from a large international study [J].

Taylor, William ;

Gladman, Dafna ;

Helliwell, Philip ;

Marchesoni, Antonio ;

Mease, Philip ;

Mielants, Herman .

ARTHRITIS AND RHEUMATISM, 2006, 54 (08) :2665-2673

← 1 2 →